Akkermansia Muciniphila

Akkermansia decoded: Advance offers opportunity to exploit probiotic's beneficial effects

11-Sep-2023 By Stephen Daniells

Scientists at Duke University in North Carolina are reported to be the first to decode the genetic makeup of Akkermansia, a next-generation probiotic with potential metabolic and immunological benefits.

Grape polyphenols may boost Akkermansia levels, improve the 'intestinal environment': Animal data

03-Feb-2023 By Stephen Daniells

Polyphenols from grapes may indirectly boost levels of Akkermansia muciniphila and improve the inflammatory profile of the intestines, says a new study from Rutgers University.

Elderberry polyphenols may boost Akkermansia levels: Human data

14-Nov-2022 By Stephen Daniells

Daily supplementation with 600 mg of an elderberry extract may boost diversity of the gut microbiota, with specific increases in levels of Akkermansia, says a new study from Austria and Italy.

Akkermansia may alter gene expression in the colon linked to immunity, inflammation: Study

06-Sep-2022 By Stephen Daniells

The potential health benefits of Akkermansia muciniphila may include changing the expression of genes associated with immune pathways, according to a new paper.

Akkermansia’s immune benefits linked to specific phospholipid

24-Aug-2022 By Stephen Daniells

The potential immunomodulatory properties of Akkermansia muciniphila may be linked to a specific type of phosphatidylethanolamine, says a new paper in Nature that deepens our understanding of how this bacterium supports human health.

Researchers leveraging Akkermansia know-how to accelerate probiotic candidate development

18-May-2022 By Stephen Daniells

Knowledge gleaned from the commercialization of Akkermansia muciniphila should lead to an accelerated path to market for a novel probiotic candidate for weight management, says the researcher behind both developments.

Probiotic Akkermansia strain may protect against cognitive dysfunction

31-Aug-2021 By Stephen Daniells

A specific strain of Akkermansia muciniphila may reverse the detrimental cognitive effects of a high-fat, high-cholesterol (HFHC) diet, including for measures of working memory and recognition, says a new study in rats.

AstaReal builds IP for Astaxanthin to support ‘next-gen’ beneficial gut bacteria

10-May-2021 By Stephen Daniells

The US Patent and Trademark Office has granted a patent covering the use of astaxanthin to boost levels of Akkermansia muciniphila.

Akkermansia levels linked to lower obesity risk: American Gut Project data

28-Oct-2020 By Stephen Daniells

High relative abundance of bacteria in the genus Akkermansia may be associated with a lower risk of obesity, according to a new analysis of data from 10,534 participants in the American Gut Project.